A hope renewed: Gilead’s Yeztugo approved by FDA, marking a turning point in HIV prevention

On 18 June 2025, Gilead Sciences—the pharmaceutical company behind the groundbreaking new treatment—announced that the U.S. FDA had officially approved its latest drug. Named Yeztugo (lenacapavir), this innovative medication is now the first and only HIV prevention drug available that requires just two doses a year.
The Human Immunodeficiency Virus (HIV), which swept across the world in the 1980s and 1990s, has taken the lives of millions and left deep scars in communities across the globe....
2 min read
Maldives National Debt 94,001,001,001.00 MVR for every single Maldivian

More From The Latest Edition